These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Compare the efficacy and safety of long-acting anticholinergic and a combination of inhaled steroids and long-acting beta-2 agonist in moderate chronic obstructive pulmonary disease. Saraç P; Sayıner A Tuberk Toraks; 2016 Jun; 64(2):112-8. PubMed ID: 27481077 [TBL] [Abstract][Full Text] [Related]
23. Tiotropium versus salmeterol in COPD. Oba Y N Engl J Med; 2011 Jun; 364(26):2553; author reply 2553-4. PubMed ID: 21714654 [No Abstract] [Full Text] [Related]
24. The value of early diagnosis for effective management of chronic obstructive pulmonary disease. Doherty DE; Chapman KR; Martinez FJ; Belfer MH J Fam Pract; 2007 Oct; 56(10 Suppl Value):S1-24. PubMed ID: 17949606 [No Abstract] [Full Text] [Related]
26. Can β2-adrenoceptor agonists, anticholinergic drugs, and theophylline contribute to the control of pulmonary inflammation and emphysema in COPD? Zhang WH; Zhang Y; Cui YY; Rong WF; Cambier C; Devillier P; Bureau F; Advenier C; Gustin P Fundam Clin Pharmacol; 2012 Feb; 26(1):118-34. PubMed ID: 22044554 [TBL] [Abstract][Full Text] [Related]
27. [COPD treatment by drugs]. Nafti S Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S58-10S60. PubMed ID: 17127967 [No Abstract] [Full Text] [Related]
28. [New drug therapy of chronic obstructive pulmonary disease]. Kino H Nihon Rinsho; 2003 Dec; 61(12):2175-80. PubMed ID: 14674329 [TBL] [Abstract][Full Text] [Related]
30. Bronchodilator combination therapy for the treatment of chronic obstructive pulmonary disease. Sethi S; Cote C Curr Clin Pharmacol; 2011 Feb; 6(1):48-61. PubMed ID: 21235463 [TBL] [Abstract][Full Text] [Related]
31. Evaluating the Impact of Triple Therapy on Mortality in Copd: The End is the Beginning? Kostikas K; Kyriakopoulos C; Gogali A COPD; 2022; 19(1):57-60. PubMed ID: 35050797 [No Abstract] [Full Text] [Related]
32. Inhaled magnesium sulfate in the treatment of acute asthma in children. Normansell R; Knightly R; Milan SJ; Knopp-Sihota JA; Rowe BH; Powell C Paediatr Respir Rev; 2018 Mar; 26():31-33. PubMed ID: 29456076 [No Abstract] [Full Text] [Related]
34. Effects of tiotropium and other long acting bronchodilators in chronic obstructive pulmonary disease. Currie GP; Rossiter C; Miles SA; Lee DK; Dempsey OJ Pulm Pharmacol Ther; 2006; 19(2):112-9. PubMed ID: 15970450 [TBL] [Abstract][Full Text] [Related]
35. Triple therapy for the management of COPD: a review. Gaebel K; McIvor RA; Xie F; Blackhouse G; Robertson D; Assasi N; Hernandez P; Goeree R COPD; 2011 Jun; 8(3):206-43. PubMed ID: 21513437 [TBL] [Abstract][Full Text] [Related]
36. The future of combining inhaled drugs for COPD. Bjerg A; Lundbäck B; Lötvall J Curr Opin Pharmacol; 2012 Jun; 12(3):252-5. PubMed ID: 22465638 [TBL] [Abstract][Full Text] [Related]
37. Pharmacology of bronchodilators. Booker R Nurs Times; 2004 Feb 10-16; 100(6):54-7, 59. PubMed ID: 15000031 [TBL] [Abstract][Full Text] [Related]
38. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease? Salama RO; Young PM; Rogueda P; Lallement A; Iliev I; Traini D Expert Opin Pharmacother; 2011 Aug; 12(12):1913-32. PubMed ID: 21714776 [TBL] [Abstract][Full Text] [Related]